Anhui Huaheng Biotechnology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Huaheng Biotechnology Co., Ltd.

Why is Anhui Huaheng Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 30.10% and Operating profit at -12.80% over the last 5 years

The company has declared Negative results for the last 5 consecutive quarters

ROCE(HY) Lowest at 6.82%
PRE-TAX PROFIT(Q) At CNY 54.45 MM has Fallen at -43.62%
NET PROFIT(Q) At CNY 51.1 MM has Fallen at -40.98%

With ROE of 5.54%, it has a expensive valuation with a 2.80 Price to Book Value

Over the past year, while the stock has generated a return of -1.47%, its profits have fallen by -63.9%
At the current price, the company has a high dividend yield of 0.5

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 14.61% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -1.47% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Anhui Huaheng Biotechnology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Anhui Huaheng Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Anhui Huaheng Biotechnology Co., Ltd.

3.71%

-1.00

42.37%

China Shanghai Composite

15.44%

1.01

14.52%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

30.10%

EBIT Growth (5y)

-12.80%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

2.30

Net Debt to Equity (avg)

0.46

Sales to Capital Employed (avg)

0.65

Tax Ratio

7.37%

Dividend Payout Ratio

30.49%

Pledged Shares

Institutional Holding

ROCE (avg)

14.98%

ROE (avg)

17.16%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.80

EV to EBIT

55.39

EV to EBITDA

26.69

EV to Capital Employed

2.18

EV to Sales

3.31

PEG Ratio

Dividend Yield

0.54%

ROCE (Latest)

3.94%

ROE (Latest)

5.54%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET SALES(Q)

Highest at CNY 683.61 MM

-28What is not working for the Company

ROCE(HY)

Lowest at 6.82%

PRE-TAX PROFIT(Q)

At CNY 54.45 MM has Fallen at -43.62%

NET PROFIT(Q)

At CNY 51.1 MM has Fallen at -40.98%

RAW MATERIAL COST(Y)

Grown by 25.41% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.6%

INTEREST(Q)

Highest at CNY 12.54 MM

Here's what is working for Anhui Huaheng Biotechnology Co., Ltd.

Net Sales

Highest at CNY 683.61 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Net Sales

At CNY 683.61 MM has Grown at 37.24%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Here's what is not working for Anhui Huaheng Biotechnology Co., Ltd.

Interest

At CNY 12.54 MM has Grown at 16.68%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 54.45 MM has Fallen at -43.62%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 51.1 MM has Fallen at -40.98%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

Highest at CNY 12.54 MM

in the last five periods and Increased by 16.68% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 4.6%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 25.41% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales